Sascha Trujillo
|
 |
Of the 27,713 patients online pharmacy in the final sample, 54% received at least 181 days of treatment. Comorbid substance abuse was associated with fewer days of treatment, whereas other psychiatric contraception pharmacy no comorbidities increased the length of treatment. Women, married patients, older patients, online pharmacy and whites were more likely than online drugstore online others to have higher-quality antidepressant drug treatment. In considering differences among facilities, we found that it is critical to control for remeron relevant patient characteristics.. This article examines the use of hashish medication cheap tramadol common sleeping in the treatment of major depression in the Department of Veterans Affairs (VA) during antibiotics the 2001 fiscal year and considers the relationship of patient as Job, drug, provider, and facility to adherence to medication treatment guidelines. antibiotics Indicators were constructed that noted whether patients newly treated with antidepressants (i.e., with no prescription in the previous 8 weeks) received at least 180 days (continuation phase) of antidepressant drug treatment (84- drug fioricet and 140-day measures were also considered). Logistic regression with and without center fixed effects and generalized estimation equations drug fioricet were used to identify patient, drug, and facility characteristics that were associated with these treatment quality indicators. Measuring quality of pharmacotherapy for depression in a national health care system.OBJECTIVES. We found the specific antidepressant drug used has little impact on quality. Although significant differences among facilities were found in the unadjusted rates (similar to those used by HEDIS), these diminished greatly after controlling for relevant covariates. Prescription drug records for all VA outpatients diagnosed with major depression (International Classification of Diseases, 9th edition, code 296.2 or 296.3) were collected for through September 2001. We found few differences resulting from provider type. In the nation's largest mental health system, quality of pharmacotherapy for depression, at least by one standard measure, is relatively good. This is higher than recent rates reported by Health Employer Data and Information Set (HEDIS) for the general population, although our measures and those used by HEDIS are not exactly the same. Contrary to previous nose around, we find few significant differences among specific antidepressant agents prescribed in this large sample.
|